BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bridges JF, Gallego G, Blauvelt BM. Controlling liver cancer internationally: A qualitative study of clinicians' perceptions of current public policy needs. Health Res Policy Syst 2011;9:32. [PMID: 21798002 DOI: 10.1186/1478-4505-9-32] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Bridges JFP, Paly VF, Barker E, Kervitsky D. Identifying the Benefits and Risks of Emerging Treatments for Idiopathic Pulmonary Fibrosis: A Qualitative Study. Patient 2015;8:85-92. [DOI: 10.1007/s40271-014-0081-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
2 Wang Z, Yang G, Nie P, Fu J, Wang X, Liu D. Dynamical observation on biological progression of VX2 liver tumors to identify the optimal time for intervention in animal models. PLoS One 2013;8:e74327. [PMID: 23977399 DOI: 10.1371/journal.pone.0074327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
3 Guo M, Gao X, Song H, Gu Y, Christie P, Wu S, Fan X. Anti-tumor effect of synthetic baicalin-rare earth metal complex drugs on SMMC-7721 cells. Environ Geochem Health 2020;42:3851-64. [PMID: 32607700 DOI: 10.1007/s10653-020-00630-2] [Reference Citation Analysis]
4 Purnell TS, Lynch TJ, Bone L, Segal JB, Evans C, Longo DR, Bridges JF. Perceived Barriers and Potential Strategies to Improve Self-Management Among Adults with Type 2 Diabetes: A Community-Engaged Research Approach. Patient 2016;9:349-58. [PMID: 26939674 DOI: 10.1007/s40271-016-0162-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
5 Bridges JF, Gallego G, Kudo M, Okita K, Han KH, Ye SL, Blauvelt BM. Identifying and prioritizing strategies for comprehensive liver cancer control in Asia. BMC Health Serv Res 2011;11:298. [PMID: 22047535 DOI: 10.1186/1472-6963-11-298] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
6 Bridges JF, Joy SM, Blauvelt BM, Yan W, Marsteller JA. An international comparison of stakeholder motivation to implement liver cancer control. Health Policy Plan 2015;30:645-55. [PMID: 24974105 DOI: 10.1093/heapol/czu044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
7 Gallego G, Bridges JF, Flynn T, Blauvelt BM, Niessen LW. Using best-worst scaling in horizon scanning for hepatocellular carcinoma technologies. Int J Technol Assess Health Care 2012;28:339-46. [PMID: 22980714 DOI: 10.1017/S026646231200027X] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
8 Bridges JF, Joy SM, Gallego G, Blauvelt BM, Geschwind JH, Pawlik TM. Priorities for Hepatocellular Carcinoma (HCC) Control: A Comparison of Policy Needs in Five European Countries. Journal of Comparative Policy Analysis: Research and Practice 2012;14:352-68. [DOI: 10.1080/13876988.2012.698581] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
9 Gélat P, ter Haar G, Saffari N. A comparison of methods for focusing the field of a HIFU array transducer through human ribs. Phys Med Biol 2014;59:3139-71. [DOI: 10.1088/0031-9155/59/12/3139] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]